IFN-γ, normally undetectable in the CNS but measurable during the symptomatic phase of MS and EAE, has been shown to enhance inflammation in the CNS and exacerbate clinical symptoms in MS patients and EAE mice31, 32, 33. Here, IFNG is linked to myeloid sarcoma.